← Back to headlines
Celcuity Projects $2.5B Annual Peak Revenue for Gedatolisib
Celcuity has outlined a potential $2.5 billion in annual peak revenue for its drug gedatolisib, as the company progresses through pivotal clinical milestones and prepares for commercial launch.
26 Mar, 00:16 — 26 Mar, 00:16
Sources
Showing 1 of 1 sources
Related Stories
USPS Confirms Fuel Surcharge Amid Rising Oil Prices; Local Fuel Costs Continue to Climb
just now
South Korea to Submit Extra Budget Bill Amid Economic Impacts of War
12m ago
Karnataka CM Defends State Budget, Cites Fiscal Prudence
20m ago
Nigerian Court Upholds $13M Forfeiture Linked to Aisha Achimugu
23m ago